Cargando…

Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma

AIM: Disease-associated healthcare expenditures are generally calculated using matched comparisons or regression-based analyses, but little is known about their differences in estimates. This aim of this study was to compare the differences between disease-associated healthcare expenditures estimate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Haruhisa, Sato, Daisuke, Moriwaki, Kensuke, Ishida, Haku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425973/
https://www.ncbi.nlm.nih.gov/pubmed/32790706
http://dx.doi.org/10.1371/journal.pone.0237316
_version_ 1783570602443931648
author Fukuda, Haruhisa
Sato, Daisuke
Moriwaki, Kensuke
Ishida, Haku
author_facet Fukuda, Haruhisa
Sato, Daisuke
Moriwaki, Kensuke
Ishida, Haku
author_sort Fukuda, Haruhisa
collection PubMed
description AIM: Disease-associated healthcare expenditures are generally calculated using matched comparisons or regression-based analyses, but little is known about their differences in estimates. This aim of this study was to compare the differences between disease-associated healthcare expenditures estimated using these 2 methods. METHODS: In this retrospective cohort study, a matched comparison was first conducted by matching cases with controls using sex, age, and comorbidities to estimate disease-associated expenditures. The cases were then used in a fixed-effects analysis that compared expenditures before and after disease occurrence. The subjects were adults (≥20 years) with primary hepatocellular carcinoma (HCC) who underwent treatment (including surgical resection, locoregional therapy, transcatheter arterial chemoembolization, and transarterial embolization) at a Japanese hospital between April 2010 and March 2018. We calculated the total healthcare expenditures per patient per month according to treatment and disease phase (initial, continuing, and terminal). RESULTS: There were 14,923 cases in the initial/continuing phases and 15,968 cases in the terminal phase. In the initial/continuing phases, 3,552 patients underwent surgical resection only, with HCC-associated expenditures of $5,555 according to the matched comparison and $5,889 according to the fixed-effects analysis (proportional difference: 94.3%). The initial phase expenditures were approximately 9% higher in the fixed-effects analysis, whereas the continuing phase expenditures were approximately 7% higher in the matched comparison. The expenditures in the terminal phase were 93.1% higher in the fixed-effects analysis. CONCLUSIONS: The 2 methods produced similar estimates of HCC-associated healthcare expenditures in the initial/continuing phases. However, terminal phase expenditures were substantially different between the methods.
format Online
Article
Text
id pubmed-7425973
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74259732020-08-20 Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma Fukuda, Haruhisa Sato, Daisuke Moriwaki, Kensuke Ishida, Haku PLoS One Research Article AIM: Disease-associated healthcare expenditures are generally calculated using matched comparisons or regression-based analyses, but little is known about their differences in estimates. This aim of this study was to compare the differences between disease-associated healthcare expenditures estimated using these 2 methods. METHODS: In this retrospective cohort study, a matched comparison was first conducted by matching cases with controls using sex, age, and comorbidities to estimate disease-associated expenditures. The cases were then used in a fixed-effects analysis that compared expenditures before and after disease occurrence. The subjects were adults (≥20 years) with primary hepatocellular carcinoma (HCC) who underwent treatment (including surgical resection, locoregional therapy, transcatheter arterial chemoembolization, and transarterial embolization) at a Japanese hospital between April 2010 and March 2018. We calculated the total healthcare expenditures per patient per month according to treatment and disease phase (initial, continuing, and terminal). RESULTS: There were 14,923 cases in the initial/continuing phases and 15,968 cases in the terminal phase. In the initial/continuing phases, 3,552 patients underwent surgical resection only, with HCC-associated expenditures of $5,555 according to the matched comparison and $5,889 according to the fixed-effects analysis (proportional difference: 94.3%). The initial phase expenditures were approximately 9% higher in the fixed-effects analysis, whereas the continuing phase expenditures were approximately 7% higher in the matched comparison. The expenditures in the terminal phase were 93.1% higher in the fixed-effects analysis. CONCLUSIONS: The 2 methods produced similar estimates of HCC-associated healthcare expenditures in the initial/continuing phases. However, terminal phase expenditures were substantially different between the methods. Public Library of Science 2020-08-13 /pmc/articles/PMC7425973/ /pubmed/32790706 http://dx.doi.org/10.1371/journal.pone.0237316 Text en © 2020 Fukuda et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fukuda, Haruhisa
Sato, Daisuke
Moriwaki, Kensuke
Ishida, Haku
Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma
title Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma
title_full Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma
title_fullStr Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma
title_full_unstemmed Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma
title_short Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma
title_sort differences in healthcare expenditure estimates according to statistical approach: a nationwide claims database study on patients with hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425973/
https://www.ncbi.nlm.nih.gov/pubmed/32790706
http://dx.doi.org/10.1371/journal.pone.0237316
work_keys_str_mv AT fukudaharuhisa differencesinhealthcareexpenditureestimatesaccordingtostatisticalapproachanationwideclaimsdatabasestudyonpatientswithhepatocellularcarcinoma
AT satodaisuke differencesinhealthcareexpenditureestimatesaccordingtostatisticalapproachanationwideclaimsdatabasestudyonpatientswithhepatocellularcarcinoma
AT moriwakikensuke differencesinhealthcareexpenditureestimatesaccordingtostatisticalapproachanationwideclaimsdatabasestudyonpatientswithhepatocellularcarcinoma
AT ishidahaku differencesinhealthcareexpenditureestimatesaccordingtostatisticalapproachanationwideclaimsdatabasestudyonpatientswithhepatocellularcarcinoma